Currently, the situation regarding the COVID-19 pandemic remains severe, with risks of imported infections and asymptomatic infections still present. In order to ensure that both epidemic prevention and production continue without interruption, and to ensure the safety of employees during the New Year, on the afternoon of January 29th, Mansen invited a testing agency to conduct nucleic acid testing for all employees.
Employees were seen queuing in an orderly fashion.
The company followed the principle of 鈥渨illing to test and willing to be tested鈥 by inviting a testing agency to conduct nucleic acid tests on-site, which not only reduced the burden of employees going out but also avoided the risk of contact with outsiders. In the lobby of the office building, the scene was orderly, with medical personnel in protective suits strictly adhering to testing and sampling requirements to ensure that the testing process was efficient and orderly. According to the testing personnel, nucleic acid samples were collected using throat swabs, which have a short testing time and are easy to operate.
Employees were sampling.
At the same time, the company facilitated the process by allowing employees鈥 family members to also undergo nucleic acid testing.
Family members of employees were sampling.
Nucleic acid testing not only adds a protective shield for the health of employees but also ensures public health safety. It provides peace of mind for both employees and their families, and assures the community as well, injecting an effective boost into the company鈥檚 epidemic prevention efforts! Mansen will further refine its prevention and control measures, strengthen employees鈥 awareness of prevention and control, and enhance their initiative and consciousness in implementing preventative measures, building a solid firewall against the pandemic!
